about
Depletion of proBNP1-108 in patients with heart failure prevents cross-reactivity with natriuretic peptidesNon-degenerative mild cognitive impairment in elderly people and use of anticholinergic drugs: longitudinal cohort studyLong-term post-operative cognitive decline in the elderly: the effects of anesthesia type, apolipoprotein E genotype, and clinical antecedents.Association of adverse childhood environment and 5-HTTLPR Genotype with late-life depression.Skeletal Muscle Insulin Resistance and Absence of Inflammation Characterize Insulin-Resistant Grade I Obese Women.Multi-Marker Strategy in Heart Failure: Combination of ST2 and CRP Predicts Poor Outcome.Urinary Biomarkers IGFBP7 and TIMP-2 for the Diagnostic Assessment of Transient and Persistent Acute Kidney Injury in Critically Ill Patients.Protein biochip systems for the clinical laboratory.Determinants of homocysteine levels in Ivorian rural population.Diagnostic and prognostic value of soluble CD14 subtype (Presepsin) for sepsis and community-acquired pneumonia in ICU patients.Lipid lowering agents, cognitive decline, and dementia: the three-city study.Biological and psychological predictors of posttraumatic stress disorder onset and chronicity. A one-year prospective study.Diagnostic accuracy of combined cardiac troponin and copeptin assessment for early rule-out of myocardial infarction: a systematic review and meta-analysis.The effect of an adverse psychological environment on salivary cortisol levels in the elderly differs by 5-HTTLPR genotype.Osteoprotegerin and sclerostin in chronic kidney disease prior to dialysis: potential partners in vascular calcifications.Plasma PCSK9 concentrations during the course of nondiabetic chronic kidney disease: Relationship with glomerular filtration rate and lipid metabolism.How to interpret cardiac biomarkers in renal failure and elderly?Adverse childhood environment and late-life cognitive functioning.Do lipids and apolipoproteins predict coronary heart disease under statin and fibrate therapy in the primary prevention setting in community-dwelling elderly subjects? The 3C Study.Homocysteine and inflammation as main determinants of oxidative stress in the elderly.Protein biochip array technology to monitor rituximab in rheumatoid arthritis.Heterogeneity in HPA axis dysregulation and serotonergic vulnerability to depression.Increased CRP levels may be a trait marker of suicidal attempt.Markers of bone remodeling are associated with arterial stiffness in renal transplanted subjects.Impact of sleep disturbances on kidney function decline in the elderly.Long term reference change value of creatinine in HIV-positive patients with anti-retroviral therapy: A new tool in clinical practice.Performances of the heart fatty acid protein assay for the rapid diagnosis of acute myocardial infarction in ED patients.Analytical performance and clinical use of a hemoglobin A1c point-of-care analyzer in a pediatric unit.Gender and genotype modulation of the association between lipid levels and depressive symptomatology in community-dwelling elderly (the ESPRIT study).Appendicular skeletal muscle mass is the strongest independent factor associated with femoral neck bone mineral density in adult and older men.A fenugreek seed extract selectively reduces spontaneous fat intake in overweight subjects.The relationship between apolipoprotein E4 and lipid metabolism is impaired in Alzheimer's disease.A meta-analysis of genome-wide association studies identifies ORM1 as a novel gene controlling thrombin generation potential.Evolution of lipid levels in HIV-infected children treated or not with HAART in Abidjan, Cote d'Ivoire.Lipodystrophy and metabolic disorders in HIV-1-infected adults on 4- to 9-year antiretroviral therapy in Senegal: a case-control study.Glomerular filtration rate as a determinant of free light chains in renal transplantation.Evolution of coronary artery calcifications following kidney transplantation: relationship with osteoprotegerin levels.Comparison between the enzymatic vitros assay for creatinine determination and three other methods adapted on the Olympus analyzer.[Biomarkers of cardiorenal syndrome].Evaluation of NM-BAPTA method for plasma total calcium measurement on Cobas 8000®.
P50
Q28533555-A11A7DFC-3729-4441-8A1A-A8EC972EE12AQ34407945-96C82318-B81F-495E-8FB3-31FB9AC97F97Q34806075-C7336FEC-BDBF-4B9C-B560-0DD2955B7D5FQ34806098-D185AF92-810F-4483-B0BD-6E5465B61912Q35998271-DB197A07-F26B-4212-B2AC-5DDA1FFAF7E4Q36054561-A354F81F-C2F1-4939-8710-1F03B48F6601Q36248788-F67982AC-5110-40D4-AA03-FF7B4B41A842Q36322911-ACFBB123-2265-4449-A128-867D432A9106Q36568680-AF187465-6DE1-468A-85A8-C6BA01AEC270Q37075366-74D1CF65-6B6E-41AB-B396-C2ED481BA618Q37095998-41E32F9E-E771-4E36-A126-AE8BB0ED188AQ37486858-4280D81E-6394-4CDB-9E9C-1B6A805599CDQ37599608-5012AA1F-BE33-44A5-8CC4-C3590A722774Q37725253-D0CD334A-9851-49F2-A0F0-02B4562B07A0Q38411782-7F2103CC-C804-486E-A026-7A96B0C31069Q38845751-453D8DCA-7611-48FA-9D5E-70C8052B35D0Q38919102-AA387E78-3514-4E7A-A050-89EF0E02D611Q39287076-2FB9E933-DB57-47D3-BC05-EE8A8F902B4AQ39809956-0C074C89-170F-4F87-B054-A58F1104724AQ39904954-7A2A04B8-A7C8-4C60-B84C-0CCB801A9CDFQ40002229-792A8992-CBC5-4C5B-BF9E-7B1E6846C6D0Q40407179-083D1FDF-CCD1-45DA-BB8D-BA7FC3F3B540Q40880663-D51106C7-9463-4958-A8A7-C737D50F80A6Q41003926-A49CD05A-20D4-4CAC-9D18-330216C4BB79Q41066149-A2330480-EE5A-4E41-89A6-C594B142058EQ41533983-83CA0A11-EB39-4D84-B744-0C9C4B3E148FQ41641074-0BC58B6A-7E8F-47D6-BF9E-51BB52D3EF81Q42768864-FBD6E322-AE5D-4E5A-B3A3-9D394D793DF9Q43033181-E601FFF8-C0D5-42FC-A1BA-F5827E07427EQ43077999-D344FE14-4290-4698-B8C8-CCD489F3F4CCQ43216294-6DA09C15-5C69-4696-B874-ED12202F90BBQ43642127-9EBBC7D5-B46E-457D-9D05-CF4A79058A27Q43719755-C5002C25-4A9B-4426-8812-3ADA6203D438Q44355459-4130613F-855A-435C-B40B-B42B82D7C295Q44357137-F6A3AFA4-5988-4686-BCD2-FC924A418159Q44422779-79577A8F-CF78-4751-AB00-089AAE54F07AQ44495582-CB07B730-1990-4C84-8EE3-D7FAD4C564BCQ44653934-932B4064-1A85-4657-BD78-E423D50EA28DQ45077505-9815F8DD-4777-41BA-9C6E-6A90DF987655Q45328466-4961FA0E-C819-4842-BC22-F4F90A6464BE
P50
description
Forscher
@de
chercheur
@fr
investigador
@es
researcher
@en
ricercatore
@it
研究者
@zh
name
A M Dupuy
@ast
A M Dupuy
@en
A M Dupuy
@es
A M Dupuy
@nl
type
label
A M Dupuy
@ast
A M Dupuy
@en
A M Dupuy
@es
A M Dupuy
@nl
prefLabel
A M Dupuy
@ast
A M Dupuy
@en
A M Dupuy
@es
A M Dupuy
@nl
P31
P496
0000-0001-6538-3944